+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
HIV Self-Test Kit Market by Distribution Channel (Diagnostic Laboratories, Hospital & Clinic, Online Retail), Product Type (Blood-Based, Oral Fluid-Based), Technology, End User, Sales Mode, Pricing Tier, HIV Type, Age Group, Gender - Global Forecast 2025-2030- Product Image
HIV Self-Test Kit Market by Distribution Channel (Diagnostic Laboratories, Hospital & Clinic, Online Retail), Product Type (Blood-Based, Oral Fluid-Based), Technology, End User, Sales Mode, Pricing Tier, HIV Type, Age Group, Gender - Global Forecast 2025-2030- Product Image
New

HIV Self-Test Kit Market by Distribution Channel (Diagnostic Laboratories, Hospital & Clinic, Online Retail), Product Type (Blood-Based, Oral Fluid-Based), Technology, End User, Sales Mode, Pricing Tier, HIV Type, Age Group, Gender - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120219
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Early detection of HIV remains a cornerstone of public health efforts to reduce transmission and improve patient outcomes. Recent breakthroughs in self-testing technologies have empowered individuals with the ability to check their status privately and conveniently, reshaping traditional healthcare touchpoints.

As regulatory bodies adapt to accommodate at-home diagnostics, manufacturers and distributors alike are recalibrating their strategies to meet evolving consumer expectations and policy requirements. This environment of rapid change highlights the need for a clear, holistic understanding of market dynamics.

This executive summary synthesizes the most salient developments influencing the HIV self-test kit landscape, from technological advancements and consumer behavior shifts to regulatory decisions and cost pressures. Through a detailed segmentation analysis and regional perspective, stakeholders will gain the insights required to optimize product portfolios, refine distribution approaches, and capitalize on emerging growth opportunities.

Understanding the Fundamental Shifts Driven by Technological Innovation Consumer Empowerment and Decentralized Testing Models in HIV Self-Diagnostics

Technological innovation has served as a catalyst for the rapid evolution of the HIV self-test kit arena. With the proliferation of mobile and web-based platforms, consumers now expect seamless digital experiences that guide them through sampling, testing, and result interpretation. At the same time, simplified sample collection methods have reduced user error and expanded accessibility in non-clinical settings.

Integration with telehealth services has further extended the reach of at-home testing kits. Remote consultations and virtual support networks have provided reassurance to users and strengthened confidence in self-diagnosis. This trend has also opened new channels for partnerships between test kit manufacturers and digital health providers.

Regulatory bodies, informed by clinical validation studies and real-world evidence, have responded by streamlining approval pathways and broadening reimbursement frameworks. These changes have contributed to a more favorable environment for innovation, encouraging investment in next-generation assay chemistries and user-centric packaging designs.

Collectively, these transformative shifts are redefining expectations around convenience, accuracy, and affordability. Stakeholders across the value chain are now challenged to balance technological sophistication with ease of use and regulatory compliance, all while accelerating time-to-market.

Evaluating How Recent United States Tariff Revisions Are Reshaping Supply Chains Cost Structures and Sourcing Strategies for HIV Self-Test Kits

United States government tariff revisions slated for 2025 are poised to exert significant influence on the global HIV self-test kit supply chain and cost structures. Heightened duties on imported components could translate into upward pressure on end-user pricing, challenging manufacturers to reassess sourcing strategies and explore alternative supply bases.

In response, several producers have initiated relocation of key manufacturing processes to regions with more favorable trade agreements. This strategic pivot aims to mitigate cost increases while preserving product quality and regulatory compliance. Additionally, there is growing emphasis on supplier diversification to reduce reliance on any single geographic source of assay reagents or packaging materials.

To maintain competitive pricing, some market participants are optimizing their logistics networks by consolidating shipments and renegotiating freight contracts. Others are absorbing portions of the tariff impact through internal cost efficiencies, leveraging automation and lean manufacturing principles to safeguard margins.

Looking ahead, sustained dialogue with policy makers and trade associations will be critical. By proactively engaging in advocacy efforts and monitoring tariff trajectories, stakeholders can anticipate further adjustments and align their operational footprints accordingly.

Revealing Key Market Segmentation Insights That Define Distribution Channels Product Formats Technologies and Consumer Demographics in HIV Self-Testing

The market has been extensively examined across diagnostic laboratories, hospital and clinic environments, online retail channels that encompass both mobile applications and website platforms, and pharmacy outlets subdivided into chain and independent networks. Each distribution channel reveals unique adoption patterns driven by factors such as consumer preferences for privacy, professional oversight, and purchase convenience.

In terms of product type, there is a clear delineation between blood-based self-test options, which include finger prick and venous sampling kits, and oral fluid-based tests that utilize cheek swabs. While blood-based formats tend to offer high sensitivity, oral fluid options are often perceived as less invasive and more user-friendly.

Technological categorizations span enzyme immunoassays, lateral flow assays differentiated into colorimetric and fluorescent modalities, and advanced microfluidic assays. Enzyme immunoassays continue to set benchmarks for analytical accuracy, whereas lateral flow and microfluidic platforms prioritize rapid results and simplified workflows.

From an end user standpoint, healthcare facilities comprising clinics and hospitals maintain strong demand for bulk procurement and professional training, while individual consumers drive the at-home testing segment by seeking autonomy and discretion. Sales modes are distinguished by over-the-counter availability versus prescription-based distribution, and pricing tiers range from economy through standard to premium offerings.

Further segmentation by HIV coverage reveals kit variations addressing dual virus detection as well as assays specific to HIV-1 or HIV-2. Demographic breakdowns by age groups-below 18, 19 to 35, 36 to 50, and above 50-and by gender categories of female and male users provide additional granularity for targeted marketing and product development strategies.

Synthesizing Regional Market Dynamics Across the Americas Europe Middle East & Africa and Asia-Pacific to Uncover Growth Patterns and Barriers

In the Americas, extensive regulatory support and well-established distribution networks have propelled high adoption rates of self-test kits. Public health campaigns have intensified outreach programs, particularly in urban centers, where partnerships between government agencies and private distributors facilitate subsidized access.

Within Europe, the Middle East, and Africa, heterogeneous regulatory landscapes and variable healthcare infrastructures yield diverse growth trajectories. Western European markets display strong uptake driven by comprehensive reimbursement schemes, while emerging economies in the Middle East and Africa present both challenges and opportunities due to resource constraints and rising demand for decentralized testing solutions.

The Asia-Pacific region exhibits a dynamic blend of high-growth and mature markets. Rapid digital transformation has accelerated the adoption of mobile app-integrated testing services in countries with advanced e-health ecosystems, whereas in other parts of the region, affordability and supply chain resilience remain the predominant growth levers. Strategic collaborations with local distributors and health authorities are critical to unlocking further potential.

Profiling Leading Innovators and Strategic Collaborators Who Are Driving Competitive Differentiation and Portfolio Expansion in HIV Self-Testing

Leading innovators have differentiated themselves through diverse portfolios encompassing both blood-based and oral fluid-based self-test kits. One prominent company has advanced colorimetric and fluorescent lateral flow formats to enhance sensitivity and user confidence, while another leverages its global footprint to streamline distribution and regulatory approvals across multiple geographies.

A notable entrant in the space has capitalized on fluorescent lateral flow technology, reducing the likelihood of user interpretation errors. Concurrently, a competitor has forged alliances with telehealth platforms to embed at-home testing within virtual care pathways, broadening reach and bolstering patient engagement.

Beyond established corporations, emerging biotech firms and digital health startups are introducing microfluidic assay prototypes and integrated mobile app experiences. Collaborative research agreements between diagnostic specialists and pharmaceutical companies further illustrate the trend toward co-development, with shared expertise expediting product innovation and market entry.

Crafting Strategic Imperatives and Investment Priorities to Strengthen Market Positioning Enhance Accessibility and Drive Sustainable Growth

Manufacturers should prioritize investments in digital integration to enrich user experiences and support telehealth partnerships. By embedding intuitive mobile interfaces and real-time result reporting, test providers can enhance adherence and foster long-term engagement.

Collaborating with public health organizations and non-profit groups will strengthen community outreach efforts and expand access among under-served populations. Targeted education campaigns and subsidized pricing models can address affordability barriers and drive broader adoption.

Product development roadmaps should emphasize assay accuracy, ease of use, and minimal sample requirements. Modular design frameworks and rapid prototyping can accelerate iterations, enabling quicker responses to emerging variants and scientific insights.

Lastly, proactive regulatory engagement remains essential. Early dialogue with health authorities regarding assay validation data and labeling requirements can expedite approvals and ensure seamless market entry across diverse jurisdictions.

Outlining the Comprehensive Research Methodology Combining Primary Interviews Secondary Data Analysis and Robust Validation Protocols for High-Integrity Market Insights

This analysis is grounded in a rigorous multi-stage research approach combining primary and secondary data collection. Over one hundred in-depth interviews with industry executives, regulatory experts, healthcare providers, and end users provided firsthand perspectives on evolving market dynamics.

Secondary research encompassed a thorough review of regulatory filings, clinical validation studies, patent databases, and industry publications. This process ensured a comprehensive understanding of technological innovations, policy developments, and competitive activity.

All findings were triangulated through cross-verification techniques to identify consistencies and resolve discrepancies. Key assumptions were stress-tested against alternative scenarios to validate the robustness of insights and maintain objectivity.

Finally, a structured quality control protocol, including peer reviews by subject matter specialists, was implemented to guarantee the integrity and reliability of conclusions. This methodology underpins the actionable recommendations and strategic imperatives outlined throughout the report.

Concluding Strategic Reflections on Innovation Accessibility and Collaborative Partnerships Guiding the Future of HIV Self-Test Diagnostics

The HIV self-test kit market is undergoing a period of profound transformation fueled by technological innovations, shifting regulatory landscapes, and evolving consumer preferences. As at-home diagnostics become more accessible and integrated within digital health ecosystems, stakeholders must remain agile to capitalize on emerging growth avenues and address potential headwinds.

By leveraging the insights presented on segmentation, regional trends, tariff impacts, and competitive positioning, decision-makers can refine their strategic roadmaps, optimize resource allocation, and accelerate product development cycles. Continued collaboration among manufacturers, healthcare organizations, and policymakers will be vital to improving early detection rates and advancing public health objectives.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Distribution Channel
    • Diagnostic Laboratories
    • Hospital & Clinic
    • Online Retail
      • Mobile App
      • Website
    • Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • Product Type
    • Blood-Based
      • Finger Prick
      • Venous
    • Oral Fluid-Based
      • Cheek Swab
  • Technology
    • Enzyme Immunoassay
    • Lateral Flow Assay
      • Colorimetric
      • Fluorescent
    • Microfluidic Assay
  • End User
    • Healthcare Facility
      • Clinic
      • Hospital
    • Individual Consumer
  • Sales Mode
    • Over The Counter
    • Prescription
  • Pricing Tier
    • Economy
    • Premium
    • Standard
  • HIV Type
    • Dual Virus
    • HIV-1
    • HIV-2
  • Age Group
    • 19 To 35
    • 36 To 50
    • Above 50
    • Below 18
  • Gender
    • Female
    • Male
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • OraSure Technologies, Inc.
  • Abbott Laboratories
  • bioLytical Laboratories, Inc.
  • Chembio Diagnostics Systems, Inc.
  • MedMira Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Beijing Kinghawk Pharmaceutical Co., Ltd.
  • BioSure Limited
  • Atomo Diagnostics Ltd
  • Biohit Oyj

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of smartphone-based digital connectivity features in HIV self-test kits to enable telehealth referrals and seamless result reporting
5.2. Development of low-cost lateral flow immunoassay technologies in self-test kits to expand access in underserved regions
5.3. Emergence of multiplex HIV and STI at-home self-test kits offering simultaneous screening for HIV, syphilis, and other coinfections
5.4. Increasing partnerships between nonprofit organizations and manufacturers to distribute HIV self-test kits in high-risk communities
5.5. Regulatory fast-tracking of novel HIV self-test devices driven by supportive WHO and FDA guidance for emergency use listing
5.6. Adoption of discreet packaging designs and unbranded e-commerce fulfillment to address privacy concerns among self-test users
5.7. Advancements in AI-based image analysis embedded in self-test smartphone apps to improve detection accuracy and user guidance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. HIV Self-Test Kit Market, by Distribution Channel
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospital & Clinic
8.4. Online Retail
8.4.1. Mobile App
8.4.2. Website
8.5. Pharmacy
8.5.1. Chain Pharmacy
8.5.2. Independent Pharmacy
9. HIV Self-Test Kit Market, by Product Type
9.1. Introduction
9.2. Blood-Based
9.2.1. Finger Prick
9.2.2. Venous
9.3. Oral Fluid-Based
9.3.1. Cheek Swab
10. HIV Self-Test Kit Market, by Technology
10.1. Introduction
10.2. Enzyme Immunoassay
10.3. Lateral Flow Assay
10.3.1. Colorimetric
10.3.2. Fluorescent
10.4. Microfluidic Assay
11. HIV Self-Test Kit Market, by End User
11.1. Introduction
11.2. Healthcare Facility
11.2.1. Clinic
11.2.2. Hospital
11.3. Individual Consumer
12. HIV Self-Test Kit Market, by Sales Mode
12.1. Introduction
12.2. Over the Counter
12.3. Prescription
13. HIV Self-Test Kit Market, by Pricing Tier
13.1. Introduction
13.2. Economy
13.3. Premium
13.4. Standard
14. HIV Self-Test Kit Market, by HIV Type
14.1. Introduction
14.2. Dual Virus
14.3. HIV-1
14.4. HIV-2
15. HIV Self-Test Kit Market, by Age Group
15.1. Introduction
15.2. 19 to 35
15.3. 36 to 50
15.4. Above 50
15.5. Below 18
16. HIV Self-Test Kit Market, by Gender
16.1. Introduction
16.2. Female
16.3. Male
17. Americas HIV Self-Test Kit Market
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. Argentina
18. Europe, Middle East & Africa HIV Self-Test Kit Market
18.1. Introduction
18.2. United Kingdom
18.3. Germany
18.4. France
18.5. Russia
18.6. Italy
18.7. Spain
18.8. United Arab Emirates
18.9. Saudi Arabia
18.10. South Africa
18.11. Denmark
18.12. Netherlands
18.13. Qatar
18.14. Finland
18.15. Sweden
18.16. Nigeria
18.17. Egypt
18.18. Turkey
18.19. Israel
18.20. Norway
18.21. Poland
18.22. Switzerland
19. Asia-Pacific HIV Self-Test Kit Market
19.1. Introduction
19.2. China
19.3. India
19.4. Japan
19.5. Australia
19.6. South Korea
19.7. Indonesia
19.8. Thailand
19.9. Philippines
19.10. Malaysia
19.11. Singapore
19.12. Vietnam
19.13. Taiwan
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. OraSure Technologies, Inc.
20.3.2. Abbott Laboratories
20.3.3. BioLytical Laboratories, Inc.
20.3.4. Chembio Diagnostics Systems, Inc.
20.3.5. MedMira Inc.
20.3.6. Guangzhou Wondfo Biotech Co., Ltd.
20.3.7. Beijing Kinghawk Pharmaceutical Co., Ltd.
20.3.8. BioSure Limited
20.3.9. Atomo Diagnostics Ltd
20.3.10. Biohit Oyj
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. HIV SELF-TEST KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HIV SELF-TEST KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 20. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 22. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. HIV SELF-TEST KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. HIV SELF-TEST KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 33. HIV SELF-TEST KIT MARKET: RESEARCHAI
FIGURE 34. HIV SELF-TEST KIT MARKET: RESEARCHSTATISTICS
FIGURE 35. HIV SELF-TEST KIT MARKET: RESEARCHCONTACTS
FIGURE 36. HIV SELF-TEST KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HIV SELF-TEST KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HIV SELF-TEST KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HIV SELF-TEST KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY MOBILE APP, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY FINGER PRICK, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY FINGER PRICK, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY VENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY VENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY CHEEK SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY CHEEK SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ENZYME IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ENZYME IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY COLORIMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY MICROFLUIDIC ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY MICROFLUIDIC ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY INDIVIDUAL CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY INDIVIDUAL CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ECONOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ECONOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PREMIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY PREMIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY STANDARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DUAL VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY DUAL VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV-1, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV-1, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV-2, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY HIV-2, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY 19 TO 35, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY 19 TO 35, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY 36 TO 50, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY 36 TO 50, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ABOVE 50, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY ABOVE 50, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY BELOW 18, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY BELOW 18, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HIV SELF-TEST KIT MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES HIV SELF-TEST KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 175. CANADA HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. CANADA HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. CANADA HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 178. CANADA HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 179. CANADA HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. CANADA HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. CANADA HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. CANADA HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. CANADA HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 184. CANADA HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 185. CANADA HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 186. CANADA HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 187. CANADA HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. CANADA HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. CANADA HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 190. CANADA HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 191. CANADA HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. CANADA HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. CANADA HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 194. CANADA HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 195. CANADA HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 196. CANADA HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 197. CANADA HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 198. CANADA HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 199. CANADA HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. CANADA HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. CANADA HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 204. CANADA HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 208. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 209. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 214. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 215. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 216. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 217. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 220. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 221. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 228. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 229. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY SALES MODE, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY PRICING TIER, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY HIV TYPE, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA HIV SELF-TEST KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 332. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2018-2024 (USD MILLION)
TABLE 336. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY BLOOD-BASED, 2025-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2018-2024 (USD MILLION)
TABLE 338. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY ORAL FLUID-BASED, 2025-2030 (USD MILLION)
TABLE 339. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 340. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2024 (USD MILLION)
TABLE 342. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY LATERAL FLOW ASSAY, 2025-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM HIV SELF-TEST KIT MARKET SIZE, BY HEALTHCARE FACILITY,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this HIV Self-Test Kit market report include:
  • OraSure Technologies, Inc.
  • Abbott Laboratories
  • bioLytical Laboratories, Inc.
  • Chembio Diagnostics Systems, Inc.
  • MedMira Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Beijing Kinghawk Pharmaceutical Co., Ltd.
  • BioSure Limited
  • Atomo Diagnostics Ltd
  • Biohit Oyj

Related Topics

Related Reports

HIV Rapid Test Kits Market - Focused Insights 2025-2030 - Product Image

HIV Rapid Test Kits Market - Focused Insights 2025-2030

  • Report
  • 132 Pages
  • Global
From
HIV Rapid Test Kits Market - Global Outlook & Forecast 2023-2028 - Product Image

HIV Rapid Test Kits Market - Global Outlook & Forecast 2023-2028

  • Report
  • 266 Pages
  • Global
From
HIV or AIDS Diagnostics Market by Test Type (Antibody Tests, CD4 Tests, Viral Load Tests), Type of Product (Consumables & Reagents, Instruments & Kits, Software), Testing Method, End-User, Application - Global Forecast 2025-2030 - Product Image

HIV or AIDS Diagnostics Market by Test Type (Antibody Tests, CD4 Tests, Viral Load Tests), Type of Product (Consumables & Reagents, Instruments & Kits, Software), Testing Method, End-User, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
At-home Self Testing Kits Market Distribution by Type of Test Format, Type of Biofluid Analyzed Therapeutic Area and Key Geographical Regions, Europe, Asia-Pacific, Africa and South America): Industry Trends and Global Forecasts, 2022-2035 - Product Image

At-home Self Testing Kits Market Distribution by Type of Test Format, Type of Biofluid Analyzed Therapeutic Area and Key Geographical Regions, Europe, Asia-Pacific, Africa and South America): Industry Trends and Global Forecasts, 2022-2035

  • Report
  • 450 Pages
  • Africa, Asia Pacific, ... Africa, Asia Pacific, Europe, Global
From
Human Immunodeficiency Virus (HIV) Rapid Test Kits - Global Strategic Business Report - Product Image

Human Immunodeficiency Virus (HIV) Rapid Test Kits - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.